This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Precision Medicine Conference" (IPMC 2023) scheduled during April 24-26, 2023 in Orlando, Florida, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at email@example.com or call + 1 (702) 988 2320.
Pharmacogenomics is the study of how genes influence a person's pharmacological response. This relatively new area combines pharmacology (drug science) and genomics (the study of genes and their functions) to create effective, safe therapies and doses that are personalized to a person's genetic makeup. Pharmacogenomics is a pre-requisite for tailored medicine. It also combines pharmacology and genomics to learn how heredity affects the human body's medication response (classically correlating gene expression or SNPs with drug efficacy). Pharmacogenomics is still in its preliminary stages. Its application is currently limited, but novel ways are being investigated in clinical trials.